March 2020 Economic and Fiscal Update As a result of the response to the COVID-19 outbreak, the government is planning for a deficit of $20.5 billion in 2020-21. The government will table a budget no later than November 15, 2020. Summary: The government proposes to retroactively raise the EHT exemption…
Elizabeth Voss
LSO put out a call to our members requesting insights on how companies are working together to combat the rapid spread of the novel COVID-19 virus. Below are some examples of how we, as a community are helping to control the outbreak. Member Announcements Amgen Canada: Amgen will provide its…
Vancouver, Canada – January 9, 2020: With a shared vision to be a catalyst for Canadian life sciences leading the world, adMare BioInnovations, Canada’s Global Life Sciences Venture (adMare), and Accel-Rx, Canada’s Health Sciences Accelerator (Accel-Rx), announced today they are bringing their respective capabilities and resources together under adMare to…
Life Sciences Ontario commissioned Research Etc., an established Toronto research firm, to conduct a survey of pharmaceutical and other life sciences leaders on the Canadian price regulations policy environment. Preliminary results of the survey are now available, drawing on 23 responses from unique organizations representing Canadian and global pharma leaders….
Writer: GLENN LOWSON/THE GLOBE AND MAIL Close to 300 people gathered at The Globe and Mail Centre on November 14 to join a conversation on growth strategies for the Canadian biomedical sector. Speakers agreed Canada punches above its weight in early-stage research and clinical trials but has yet to produce…
TORONTO– LSO today announced the recipients of its 2020 LSO Awards, recognizing outstanding individuals and companies contributing to the success of Ontario’s life sciences sector. The awards will be presented during LSO’s Celebration of Success Awards Dinner at Toronto’s Liberty Grand, February 26, 2020. The 2020 awardees are as follows: Lifetime Achievement…
Canadian researchers have given the world insulin, pacemakers and the discovery of stem cells, and are making headway in a number of biomedical fields, including artificial intelligence, medical imaging, quantum computing and cannabis-based treatments. Aside from research and innovation, the potential for economic success in the biomedical field is massive,…
MISSISSAUGA, Ontario — Today, BioTalent Canada and Life Sciences Ontario (LSO) announced the launch of The PetriDish™ Life Sciences Ontario job board, providing companies in one of Canada’s largest biotech hubs with a platform to attract talent. The launch of an Ontario bio-economy job board comes at a time when…
Re A Cure For Canada’s High Drug Prices (Aug. 13): The Globe and Mail compares the Liberals’ redesign of the Patented Medicine Prices Review Board to renovations on a house, with the PMPRB being the health-care system’s “plumbing.” The analogy is apt, but the conclusion that the changes are reasonable is wrong….
Complicated new regulations will set maximum allowable prices for new medicines too low to justify research and launch of medicines in Canada Changes will also exacerbate potential for mass diversion of lower-priced Canadian medicines to the United States EDMONTON, TORONTO and MONTREAL, Aug. 9, 2019 /CNW/ – The federal government’s new regulations for setting the maximum allowable…